Cloud Banner

Medical Devices

Image

Global Genetic Testing Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Published Report
  • Jan 2024
  • Global
  • 350 Pages
  • No of Tables: 1145
  • No of Figures: 36

Global Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New Born Screening, Predictive and Presymptomatic Testing, and Other Types), Technology (DNA Sequencing (NGS-Based Testing), Polymerase Chain Reaction, Microarrays, Whole Genome Sequencing, Fluorescence In Situ Hybridization (FISH), and Others), Diseases (Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Fragile X Syndrome, and Other) End User (Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, and Private Laboratories) - Industry Trends and Forecast to 2031.

Genetic Testing Market

Genetic Testing Market Analysis and Size

The rising prevalence of genetic disorders and increasing disposable income have accelerated the demand for genetic testing in healthcare facilities. The surge in innovations and technologies is also propelling the growth of the market. The global genetic testing market is growing in the forecast year due to the rising players in the market and the availability of advanced testing technologies and products. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market.

Genetic Testing MarketGenetic Testing Market

The market is growing in the forecast year due to the rise in market players and the availability of various genetic testing brands in the market. Along with this, manufacturers are engaged in producing different products in the market. The increasing government funding in the healthcare sector is further boosting the market growth. However, no cure and high cost of treatment may hamper the growth of the genetic testing market in the forecast period.

Data Bridge Market Research analyzes that the global genetic testing market is expected to reach USD 62,607,580.19 thousand by 2031, at a CAGR of 16.5% during the forecast period 2024-2031.

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016 - 2021)

Quantitative Units

Revenue in USD Thousand

Segments Covered

By Type (Carrier Testing, Diagnostic Testing, New Born Screening, Predictive and Presymptomatic Testing, and Other Types), Technology (DNA Sequencing (NGS-Based Testing), Polymerase Chain Reaction, Microarrays, Whole Genome Sequencing, Fluorescence In Situ Hybridization (FISH), and Others), Diseases (Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Fragile X Syndrome, and Other) End User (Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, and Private Laboratories)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K. Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Thermo Fisher Scientific Inc., Invitae Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Myriad Genetics, Inc., Abbott, Eurofins Scientific, Sorenson Genomics, BIO-HELIX, Biocartis, Cepheid ( A subsidiary of Danaher), PacBio, ELITechGroup, Genes2Me, Eugene Labs, Otogenetics, Mapmygenome, MedGenome, BioReference, and Natera, Inc. among others

Global Genetic Testing Market Definition

Genetic testing is a kind of medical test that identifies changes in genes, chromosomes, or proteins. The outcome of a genetic test can confirm or rule out a suspected genetic condition or aid in determining a person’s chance of developing or passing on a genetic disorder. Over 77,000 genetic tests are currently in use, and others are being developed. The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the global genetic testing market.

Global Genetic Testing Market Dynamics

Drivers

  • Growing Prevalence of Genetic Disorders

Genetic disorders may cause such severe health problems that they are incompatible with life. In most severe cases, these conditions may cause a miscarriage of an affected embryo or fetus. The rising prevalence of genetic diseases and birth defects boosts the demand for genetic testing.

  • Increase in the Adoption of Next Generation Sequencing

Genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular foundations of individual tumours and specific receptors.

NGS offers advantages in accuracy, sensitivity, and speed compared to traditional methods that have the potential to make a significant impact on the field of oncology. The need to order multiple tests to identify the causative mutation is eliminated because NGS can assess multiple genes in a single assay. Next-generation sequencing has the power to transform oncology’s outlook and push forward the vision of precision medicine by the adoption of genome-focused pharmacology for the treatment of genetic diseases. Thus, the increase in the adoption of genome-focused pharmacology for genetic disease treatment is propelling the market growth.

Genetic Testing Market

Opportunity

  • Strategic Initiatives by the Key Market Player

The demand for next generation sequencing is increasing in the market due to the increased incidence of cancer of various aetiologies’ along with the increased geriatric population across the region. The conventional diagnosis method of cancer includes tissue biopsies among others which are harsh and painful in nature. Thus, the top market players have implemented the strategy of collaboration with other market players aimed at improving business operations and profitability.

Restraint/Challenge

  • Cyber Security Concerns in Genomics

Software is known to contain vulnerabilities caused by imperfect code, and misconfiguration among others, and NGS-related software, engaged in the operation of sequencing and laboratory equipment or performing bioinformatics analyses is not different. Software vulnerabilities are exploited to gain unauthorized access to computer systems or networks, leak data, crash, or otherwise disrupt various services.

Recent Development

  • In April 2021, Biocartis and SkylineDx announced the signing of a new partnership agreement which targets the development of SkylineDx’ novel proprietary test, the Merlin Assay, on Biocartis’ rapid and easy-to-use molecular diagnostics platform Idylla. This assay is aimed at predicting a patient’s risk of nodal metastasis in melanoma

Global Genetic Testing Market Scope

The global genetic testing market is segmented into four notable segments which are based on type, technology, diseases, and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Carrier Testing
  • Diagnostic Testing
  • New Born Screening
  • Predictive and Presymptomatic Testing
  • Other Types

On the basis of type, the market is segmented into carrier testing, diagnostic testing, new born screening, predictive and presymptomatic testing, and other types.

Technology

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Whole Genome Sequencing
  • Fluorescence In Situ Hybridization (FISH)
  • Others

On the basis of technology, the market is segmented into DNA sequencing, polymerase chain reaction, microarrays, whole genome sequencing, Fluorescence In Situ Hybridization (FISH), and others.

Disease

  • Rare Genetic Disorder
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington’s Disease
  • Fragile X Syndrome
  • Other

On the basis of disease, the market is segmented into rare genetic disorder, cancer, cystic fibrosis, sickle cell anemia, duchenne muscular dystrophy, thalassemia, Huntington’s disease, fragile X syndrome, and other.

End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Private Clinics
  • Laboratory Service Providers
  • Private Laboratories

On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, private clinics, laboratory service providers, and private laboratories.

Genetic Testing Market

Global Genetic Testing Market : Regional Analysis/Insights

The genetic testing market is analyzed, and market size insights and trends are provided by country, type, technology, diseases, and end-user, as referenced above.

The countries covered in this genetic testing market report are U.S., Canada, Mexico, Germany, France, U.K. Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.

U.S. in North America is expected to dominate the market due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries. China in Asia-Pacific is expected to show significant growth in the market due to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Genetic Testing Market

Competitive Landscape and Global Genetic Testing Market Share Analysis

The genetic testing market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, Global Presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the global genetic testing market are Thermo Fisher Scientific Inc., Invitae Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Myriad Genetics, Inc., Abbott, Eurofins Scientific, Sorenson Genomics, BIO-HELIX, Biocartis, Cepheid (A subsidiary of Danaher), PacBio, ELITechGroup, Genes2Me, Eugene Labs, Otogenetics, Mapmygenome, MedGenome, BioReference, and Natera, Inc. among others.


SKU-

TABLE 1 GLOBAL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 3 GLOBAL DIAGNOSTIC TESTING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL PRENATAL TESTING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 6 GLOBAL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UUNITS)

TABLE 7 GLOBAL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 9 GLOBAL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 12 GLOBAL NEW BORN SCREENING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL PREDICTIVE AND PRESYMPTOMATIC TESTING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 18 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 20 GLOBAL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 21 GLOBAL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 22 GLOBAL CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 23 GLOBAL OTHER TYPES IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 24 GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 25 GLOBAL POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 GLOBAL POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 27 GLOBAL DNA SEQUENCING (NGS-BASED TESTING) IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 GLOBAL DNA SEQUENCING (NGS-BASED TESTING) IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 29 GLOBAL WHOLE GENOME SEQUENCING IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 30 GLOBAL MICROARRAYS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 GLOBAL MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 32 GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 GLOBAL OTHERS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 GLOBAL GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1 GLOBAL CANCER IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 3 GLOBAL SICKLE CELL ANEMIA IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL THALASSEMIA IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 6 GLOBAL RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 7 GLOBAL FRAGILE X SYNDROME IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL DUCHENNE MUSCULAR DYSTROPHY IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 9 GLOBAL HUNTINGTON'S DISEASE IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL CYSTIC FIBROSIS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL OTHERS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 12 GLOBAL GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL HOSPITALS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL CLINICS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL DIAGNOSTIC CENTERS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL PRIVATE CLINICS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL LABORATORY SERVICE PROVIDERS IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 18 GLOBAL PRIVATE LABORATORIES IN GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL GENETIC TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 20 NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 21 NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 22 NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 23 NORTH AMERICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 24 NORTH AMERICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 25 NORTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 26 NORTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 27 NORTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 28 NORTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 30 NORTH AMERICA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 NORTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 33 NORTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 35 NORTH AMERICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 36 NORTH AMERICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 37 NORTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 46 U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 48 U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 49 U.S. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 50 U.S. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 51 U.S. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 52 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 53 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 54 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 55 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 56 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 58 U.S. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 59 U.S. NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 62 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 63 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 65 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 66 U.S. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 68 U.S. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 69 U.S. CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 77 U.S. GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 78 CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 80 CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 81 CANADA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 83 CANADA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 84 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 86 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 87 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 90 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 91 CANADA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 92 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 93 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 94 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 95 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 97 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 98 CANADA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 CANADA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 100 CANADA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 101 CANADA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 102 CANADA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 103 CANADA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 104 CANADA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 105 CANADA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 106 CANADA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 107 CANADA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 108 CANADA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 109 CANADA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 110 MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 111 MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 112 MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 113 MEXICO PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 114 MEXICO PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 115 MEXICO PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 116 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 117 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 118 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 119 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 120 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 121 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 122 MEXICO NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 123 MEXICO NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 124 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 126 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 127 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 129 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 130 MEXICO EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 131 MEXICO EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 132 MEXICO EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 133 MEXICO CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 134 MEXICO GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 135 MEXICO POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 136 MEXICO DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 137 MEXICO MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 138 MEXICO GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 139 MEXICO RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 140 MEXICO CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 141 MEXICO GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 142 EUROPE GENETIC TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 143 EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 144 EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 145 EUROPE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 146 EUROPE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 147 EUROPE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 148 EUROPE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 149 EUROPE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 150 EUROPE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 151 EUROPE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 152 EUROPE NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 153 EUROPE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 154 EUROPE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 155 EUROPE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 EUROPE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 157 EUROPE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 158 EUROPE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 159 EUROPE CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 160 EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 161 EUROPE POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 162 EUROPE DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 163 EUROPE MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 164 EUROPE GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 165 EUROPE RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 166 EUROPE CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 167 EUROPE GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 168 GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 169 GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 170 GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 171 GERMANY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 172 GERMANY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 173 GERMANY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 174 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 175 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 176 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 177 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 178 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 GERMANY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 180 CANADA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 181 GERMANY NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 182 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 183 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 184 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 185 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 186 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 187 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 188 GERMANY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 189 GERMANY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 190 GERMANY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 191 GERMANY CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 192 GERMANY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 193 GERMANY POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 194 GERMANY DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 195 GERMANY MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 196 GERMANY GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 197 GERMANY RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 198 GERMANY CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 199 GERMANY GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 200 FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 201 FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 202 FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 203 FRANCE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 204 FRANCE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 205 FRANCE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 206 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 207 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 208 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 209 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 210 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 211 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 212 FRANCE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 213 FRANCE NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 214 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 215 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 216 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 217 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 218 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 219 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 220 FRANCE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 221 FRANCE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 222 FRANCE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 223 FRANCE CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 224 FRANCE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 225 FRANCE POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 226 FRANCE DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 227 FRANCE MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 228 FRANCE GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 229 FRANCE RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 230 FRANCE CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 231 FRANCE GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 232 U.K. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 233 U.K. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 234 U.K. GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 235 U.K. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 U.K. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 237 U.K. PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 238 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 239 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 240 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 241 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 242 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 243 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 244 U.K. NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 245 U.K. NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 246 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 247 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 248 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 249 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 250 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 251 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 252 U.K. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 253 U.K. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 254 U.K. EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 255 U.K. CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 256 U.K. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 257 U.K. POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 258 U.K. DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 259 U.K. MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 260 U.K. GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 261 U.K. RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 262 U.K. CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 263 U.K. GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 264 RUSSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 265 RUSSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 266 RUSSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 267 RUSSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 RUSSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 269 RUSSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 270 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 271 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 272 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 273 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 274 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 275 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 276 RUSSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 277 RUSSIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 278 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 280 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 281 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 283 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 284 RUSSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 RUSSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 286 RUSSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 287 RUSSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 288 RUSSIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 289 RUSSIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 290 RUSSIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 291 RUSSIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 292 RUSSIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 293 RUSSIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 294 RUSSIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 295 RUSSIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 296 ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 298 ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 299 ITALY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 ITALY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 301 ITALY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 302 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 303 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 304 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 305 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 306 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 307 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 308 ITALY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 309 ITALY NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 310 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 311 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 312 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 313 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 314 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 315 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 316 ITALY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 ITALY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 318 ITALY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 319 ITALY CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 320 ITALY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 321 ITALY POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 322 ITALY DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 323 ITALY MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 324 ITALY GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 325 ITALY RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 326 ITALY CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 327 ITALY GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 328 SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 329 SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 330 SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 331 SPAIN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 332 SPAIN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 333 SPAIN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 334 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 335 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 336 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 337 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 338 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 339 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 340 SPAIN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 341 SPAIN NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 342 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 343 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 344 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 345 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 346 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 347 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 348 SPAIN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 349 SPAIN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 350 SPAIN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 351 SPAIN CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 352 SPAIN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 353 SPAIN POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 354 SPAIN DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 355 SPAIN MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 356 SPAIN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 357 SPAIN RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 358 SPAIN CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 359 SPAIN GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 360 TURKEY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 361 TURKEY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 362 TURKEY GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 363 TURKEY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 364 TURKEY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 365 TURKEY PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 366 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 367 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 368 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 369 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 370 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 371 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 372 TURKEY NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 373 TURKEY NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 374 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 375 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 376 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 377 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 378 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 379 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 380 TURKEY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 381 TURKEY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 382 TURKEY EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 383 TURKEY CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 384 TURKEY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 385 TURKEY POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 386 TURKEY DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 387 TURKEY MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 388 TURKEY GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 389 TURKEY RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 390 TURKEY CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 391 TURKEY GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 392 NETHERLANDS GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 393 NETHERLANDS GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 394 NETHERLANDS GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 395 NETHERLANDS PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 396 NETHERLANDS PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 397 NETHERLANDS PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 398 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 399 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 400 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 401 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 402 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 403 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 404 NETHERLANDS NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 405 NETHERLANDS NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 406 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 407 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 408 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 409 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 410 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 411 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 412 NETHERLANDS EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 413 NETHERLANDS EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 414 NETHERLANDS EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 415 NETHERLANDS CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 416 NETHERLANDS GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 417 NETHERLANDS POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 418 NETHERLANDS DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 419 NETHERLANDS MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 420 NETHERLANDS GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 421 NETHERLANDS RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 422 NETHERLANDS CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 423 NETHERLANDS GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 424 SWITZERLAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 425 SWITZERLAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 426 SWITZERLAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 427 SWITZERLAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 428 SWITZERLAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 429 SWITZERLAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 430 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 431 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 432 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 433 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 434 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 435 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 436 SWITZERLAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 437 SWITZERLAND NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 438 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 439 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 440 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 441 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 442 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 443 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 444 SWITZERLAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 445 SWITZERLAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 446 SWITZERLAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 447 SWITZERLAND CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 448 SWITZERLAND GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 449 SWITZERLAND POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 450 SWITZERLAND DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 451 SWITZERLAND MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 452 SWITZERLAND GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 453 SWITZERLAND RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 454 SWITZERLAND CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 455 SWITZERLAND GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 456 BELGIUM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 457 BELGIUM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 458 BELGIUM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 459 BELGIUM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 460 BELGIUM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 461 BELGIUM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 462 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 463 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 464 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 465 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 466 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 467 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 468 BELGIUM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 469 BELGIUM NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 470 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 471 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 472 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 473 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 474 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 475 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 476 BELGIUM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 477 BELGIUM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 478 BELGIUM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 479 BELGIUM CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 480 BELGIUM GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 481 BELGIUM POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 482 BELGIUM DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 483 BELGIUM MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 484 BELGIUM GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 485 BELGIUM RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 486 BELGIUM CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 487 BELGIUM GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 488 REST OF EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 489 ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 490 ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 491 ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 492 ASIA-PACIFIC PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 493 ASIA-PACIFIC PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 494 ASIA-PACIFIC NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 495 ASIA-PACIFIC NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 496 ASIA-PACIFIC NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 497 ASIA-PACIFIC NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 498 ASIA-PACIFIC NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 499 ASIA-PACIFIC NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 500 ASIA-PACIFIC CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 501 ASIA-PACIFIC CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 502 ASIA-PACIFIC CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 503 ASIA-PACIFIC CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 504 ASIA-PACIFIC EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 505 ASIA-PACIFIC EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 506 ASIA-PACIFIC CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 507 ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 508 ASIA-PACIFIC POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 509 ASIA-PACIFIC DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 510 ASIA-PACIFIC MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 511 ASIA-PACIFIC GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 512 ASIA-PACIFIC RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 513 ASIA-PACIFIC CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 514 ASIA-PACIFIC GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 515 CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 516 CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 517 CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 518 CHINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 519 CHINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 520 CHINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 521 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 522 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 523 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 524 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 525 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 526 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 527 CHINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 528 CHINA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 529 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 530 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 531 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 532 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 533 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 534 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 535 CHINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 536 CHINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 537 CHINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 538 CHINA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 539 CHINA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 540 CHINA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 541 CHINA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 542 CHINA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 543 CHINA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 544 CHINA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 545 CHINA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 546 CHINA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 547 JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 548 JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 549 JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 550 JAPAN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 551 JAPAN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 552 JAPAN PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 553 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 554 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 555 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 556 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 557 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 558 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 559 JAPAN NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 560 JAPAN NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 561 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 562 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 563 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 564 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 565 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 566 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 567 JAPAN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 568 JAPAN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 569 JAPAN EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 570 JAPAN CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 571 JAPAN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 572 JAPAN POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 573 JAPAN DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 574 JAPAN MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 575 JAPAN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 576 JAPAN RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 577 JAPAN CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 578 JAPAN GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 579 .INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 580 INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 581 INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 582 INDIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 583 INDIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 584 INDIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 585 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 586 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 587 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 588 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 589 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 590 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 591 INDIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 592 INDIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 593 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 594 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 595 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 596 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 597 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 598 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 599 INDIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 600 INDIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 601 INDIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 602 INDIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 603 INDIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 604 INDIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 605 INDIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 606 INDIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 607 INDIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 608 INDIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 609 INDIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 610 INDIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 611 SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 612 SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 613 SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 614 SOUTH KOREA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 615 SOUTH KOREA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 616 SOUTH KOREA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 617 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 618 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 619 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 620 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 621 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 622 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 623 SOUTH KOREA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 624 SOUTH KOREA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 625 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 626 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 627 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 628 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 629 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 630 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 631 SOUTH KOREA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 632 SOUTH KOREA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 633 SOUTH KOREA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 634 SOUTH KOREA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 635 SOUTH KOREA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 636 SOUTH KOREA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 637 SOUTH KOREA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 638 SOUTH KOREA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 639 SOUTH KOREA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 640 SOUTH KOREA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 641 SOUTH KOREA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 642 SOUTH KOREA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 643 AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 644 AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 645 AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 646 AUSTRALIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 647 AUSTRALIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 648 AUSTRALIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 649 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 650 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 651 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 652 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 653 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 654 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 655 AUSTRALIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 656 AUSTRALIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 657 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 658 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 659 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 660 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 661 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 662 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 663 AUSTRALIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 664 AUSTRALIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 665 AUSTRALIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 666 AUSTRALIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 667 AUSTRALIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 668 AUSTRALIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 669 AUSTRALIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 670 AUSTRALIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 671 AUSTRALIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 672 AUSTRALIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 673 AUSTRALIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 674 AUSTRALIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 675 SINGAPORE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 676 SINGAPORE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 677 SINGAPORE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 678 SINGAPORE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 679 SINGAPORE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 680 SINGAPORE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 681 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 682 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 683 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 684 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 685 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 686 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 687 SINGAPORE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 688 SINGAPORE NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 689 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 690 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 691 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 692 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 693 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 694 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 695 SINGAPORE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 696 SINGAPORE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 697 SINGAPORE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 698 SINGAPORE CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 699 SINGAPORE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 700 SINGAPORE POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 701 SINGAPORE DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 702 SINGAPORE MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 703 SINGAPORE GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 704 SINGAPORE RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 705 SINGAPORE CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 706 SINGAPORE GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 707 THAILAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 708 THAILAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 709 THAILAND GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 710 THAILAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 711 THAILAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 712 THAILAND PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 713 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 714 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 715 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 716 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 717 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 718 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 719 THAILAND NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 720 THAILAND NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 721 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 722 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 723 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 724 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 725 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 726 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 727 THAILAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 728 THAILAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 729 THAILAND EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 730 THAILAND CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 731 THAILAND GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 732 THAILAND POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 733 THAILAND DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 734 THAILAND MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 735 THAILAND GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 736 THAILAND RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 737 THAILAND CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 738 THAILAND GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 739 INDONESIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 740 INDONESIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 741 INDONESIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 742 INDONESIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 743 INDONESIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 744 INDONESIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 745 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 746 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 747 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 748 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 749 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 750 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 751 INDONESIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 752 INDONESIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 753 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 754 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 755 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 756 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 757 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 758 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 759 INDONESIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 760 INDONESIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 761 INDONESIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 762 INDONESIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 763 INDONESIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 764 INDONESIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 765 INDONESIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 766 INDONESIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 767 INDONESIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 768 INDONESIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 769 INDONESIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 770 INDONESIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 771 PHILIPPINES GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 772 PHILIPPINES GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 773 PHILIPPINES GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 774 PHILIPPINES PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 775 PHILIPPINES PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 776 PHILIPPINES PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 777 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 778 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 779 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 780 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 781 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 782 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 783 PHILIPPINES NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 784 PHILIPPINES NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 785 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 786 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 787 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 788 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 789 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 790 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 791 PHILIPPINES EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 792 PHILIPPINES EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 793 PHILIPPINES EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 794 PHILIPPINES CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 795 PHILIPPINES GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 796 PHILIPPINES POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 797 PHILIPPINES DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 798 PHILIPPINES MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 799 PHILIPPINES GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 800 PHILIPPINES RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 801 PHILIPPINES CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 802 PHILIPPINES GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 803 MALAYSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 804 MALAYSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 805 MALAYSIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 806 MALAYSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 807 MALAYSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 808 MALAYSIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 809 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 810 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 811 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 812 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 813 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 814 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 815 MALAYSIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 816 MALAYSIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 817 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 818 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 819 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 820 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 821 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 822 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 823 MALAYSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 824 MALAYSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 825 MALAYSIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 826 MALAYSIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 827 MALAYSIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 828 MALAYSIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 829 MALAYSIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 830 MALAYSIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 831 MALAYSIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 832 MALAYSIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 833 MALAYSIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 834 MALAYSIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 835 VIETNAM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 836 VIETNAM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 837 VIETNAM GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 838 VIETNAM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 839 VIETNAM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 840 VIETNAM PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 841 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 842 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 843 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 844 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 845 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 846 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 847 VIETNAM NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 848 VIETNAM NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 849 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 850 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 851 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 852 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 853 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 854 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 855 VIETNAM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 856 VIETNAM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 857 VIETNAM EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 858 VIETNAM CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 859 VIETNAM GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 860 VIETNAM POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 861 VIETNAM DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 862 VIETNAM MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 863 VIETNAM GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 864 VIETNAM RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 865 VIETNAM CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 866 VIETNAM GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 867 REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 868 SOUTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 869 SOUTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 870 SOUTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 871 SOUTH AMERICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 872 SOUTH AMERICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 873 SOUTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 874 SOUTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 875 SOUTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 876 SOUTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 877 SOUTH AMERICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 878 SOUTH AMERICA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 879 SOUTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 880 SOUTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 881 SOUTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 882 SOUTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 883 SOUTH AMERICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 884 SOUTH AMERICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 885 SOUTH AMERICA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 886 SOUTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 887 SOUTH AMERICA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 888 SOUTH AMERICA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 889 SOUTH AMERICA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 890 SOUTH AMERICA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 891 SOUTH AMERICA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 892 SOUTH AMERICA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 893 SOUTH AMERICA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 894 BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 895 BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 896 BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 897 BRAZIL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 898 BRAZIL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 899 BRAZIL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 900 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 901 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 902 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 903 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 904 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 905 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 906 BRAZIL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 907 BRAZIL NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 908 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 909 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 910 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 911 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 912 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 913 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 914 BRAZIL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 915 BRAZIL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 916 BRAZIL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 917 BRAZIL CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 918 BRAZIL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 919 BRAZIL POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 920 BRAZIL DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 921 BRAZIL MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 922 BRAZIL GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 923 BRAZIL RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 924 BRAZIL CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 925 BRAZIL GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 926 ARGENTINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 927 ARGENTINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 928 ARGENTINA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 929 ARGENTINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 930 ARGENTINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 931 ARGENTINA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 932 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 933 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 934 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 935 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 936 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 937 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 938 ARGENTINA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 939 ARGENTINA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 940 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 941 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 942 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 943 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 944 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 945 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 946 ARGENTINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 947 ARGENTINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 948 ARGENTINA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 949 ARGENTINA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 950 ARGENTINA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 951 ARGENTINA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 952 ARGENTINA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 953 ARGENTINA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 954 ARGENTINA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 955 ARGENTINA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 956 ARGENTINA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 957 ARGENTINA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 958 REST OF SOUTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 959 MIDDLE EAST AND AFRICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2031(USD THOUSAND)

TABLE 960 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 961 MIDDLE EAST AND AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 962 MIDDLE EAST & AFRICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 963 MIDDLE EAST AND AFRICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 964 MIDDLE EAST & AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 965 MIDDLE EAST AND AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 966 MIDDLE EAST & AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 967 MIDDLE EAST & AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 968 MIDDLE EAST AND AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 969 MIDDLE EAST & AFRICA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 970 MIDDLE EAST & AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 971 MIDDLE EAST AND AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 972 MIDDLE EAST & AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 973 MIDDLE EAST AND AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 974 MIDDLE EAST & AFRICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 975 MIDDLE EAST AND AFRICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 976 MIDDLE EAST & AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 977 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 978 MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 979 MIDDLE EAST & AFRICA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 980 MIDDLE EAST & AFRICA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 981 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 982 MIDDLE EAST & AFRICA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 983 MIDDLE EAST & AFRICA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 984 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 985 SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 986 SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 987 SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 988 SOUTH AFRICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 989 SOUTH AFRICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 990 SOUTH AFRICA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 991 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 992 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 993 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 994 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 995 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 996 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 997 SOUTH AFRICA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 998 SOUTH AFRICA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 999 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 1000 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 1001 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 1002 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1003 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1004 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1005 SOUTH AFRICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1006 SOUTH AFRICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1007 SOUTH AFRICA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1008 SOUTH AFRICA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1009 SOUTH AFRICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1010 SOUTH AFRICA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1011 SOUTH AFRICA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1012 SOUTH AFRICA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1013 SOUTH AFRICA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1014 SOUTH AFRICA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1015 SOUTH AFRICA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1016 SOUTH AFRICA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 1017 SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1018 SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1019 SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1020 SAUDI ARABIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1021 SAUDI ARABIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1022 SAUDI ARABIA PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1023 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 1024 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 1025 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 1026 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1027 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 1028 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 1029 SAUDI ARABIA NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 1030 SAUDI ARABIA NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1031 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 1032 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 1033 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 1034 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1035 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1036 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1037 SAUDI ARABIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1038 SAUDI ARABIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1039 SAUDI ARABIA EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1040 SAUDI ARABIA CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1041 SAUDI ARABIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1042 SAUDI ARABIA POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1043 SAUDI ARABIA DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1044 SAUDI ARABIA MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1045 SAUDI ARABIA GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1046 SAUDI ARABIA RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1047 SAUDI ARABIA CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1048 SAUDI ARABIA GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 1049 UAE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1050 UAE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1051 UAE GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1052 UAE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1053 UAE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1054 UAE PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1055 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 1056 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 1057 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 1058 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1059 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 1060 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 1061 UAE NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 1062 UAE NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1063 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 1064 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 1065 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 1066 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1067 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1068 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1069 UAE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1070 UAE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1071 UAE EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1072 UAE CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1073 UAE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1074 UAE POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1075 UAE DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1076 UAE MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1077 UAE GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1078 UAE RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1079 UAE CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1080 UAE GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 1081 .ISRAEL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1082 ISRAEL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1083 ISRAEL GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1084 ISRAEL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1085 ISRAEL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1086 ISRAEL PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1087 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 1088 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 1089 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 1090 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1091 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 1092 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 1093 ISRAEL NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 1094 ISRAEL NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1095 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 1096 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 1097 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 1098 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1099 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1100 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1101 ISRAEL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1102 ISRAEL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1103 ISRAEL EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1104 ISRAEL CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1105 ISRAEL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1106 ISRAEL POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1107 ISRAEL DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1108 ISRAEL MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1109 ISRAEL GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1110 ISRAEL RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1111 ISRAEL CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1112 ISRAEL GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 1113 EGYPT GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1114 EGYPT GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1115 EGYPT GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1116 EGYPT PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1117 EGYPT PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1118 EGYPT PRENATAL TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1119 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (USD THOUSAND)

TABLE 1120 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (UNITS)

TABLE 1121 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING METHOD, 2022-2031 (ASP)

TABLE 1122 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1123 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (USD THOUSAND)

TABLE 1124 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (UNITS)

TABLE 1125 EGYPT NON-INVASIVE SCREENING IN GENETIC TESTING MARKET, BY SCREENING TYPE, 2022-2031 (ASP)

TABLE 1126 EGYPT NEW-BORN SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1127 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 1128 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (UNITS)

TABLE 1129 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TEST TYPE, 2022-2031 (ASP)

TABLE 1130 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1131 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1132 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1133 EGYPT EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 1134 EGYPT EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (UNITS)

TABLE 1135 EGYPT EXPANDED CARRIER SCREENING IN GENETIC TESTING MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 1136 EGYPT CARRIER TESTING IN GENETIC TESTING MARKET, BY MEDICAL CONDITION, 2022-2031 (USD THOUSAND)

TABLE 1137 EGYPT GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1138 EGYPT POLYMERASE CHAIN REACTION IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1139 EGYPT DNA SEQUENCING IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1140 EGYPT MICROARRAYS IN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 1141 EGYPT GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1142 EGYPT RARE GENETIC DISORDER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1143 EGYPT CANCER IN GENETIC TESTING MARKET, BY DISEASES, 2022-2031 (USD THOUSAND)

TABLE 1144 EGYPT GENETIC TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 1145 REST OF MIDDLE EAST AND AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The genetic testing market size will be worth USD 62,607,580.19 thousand by 2031.
The growth rate of the genetic testing market is 16.5% in the forecast period by 2031.
Major companies in the genetic testing market are Thermo Fisher Scientific Inc. (U.S.), Invitae Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Fulgent Genetics (U.S.), Myriad Genetics, Inc. (U.S.), Abbott (U.S.), Eurofins Scientific (Luxembourg), Sorenson Genomics (U.S.), BIO-HELIX (U.S.), Biocartis (Belgium), Cepheid (A subsidiary of Danaher) (U.S.), PacBio (U.S.), ELITechGroup (France), Genes2Me (India), Eugene Labs (India), Otogenetics (U.S.), Mapmygenome (India), MedGenome (India), BioReference (U.S.), Sema4 OpCo, Inc. (U.S.), Natera, Inc. (U.S.)
Type, technology, diseases, and end-users are the factors on which the genetic testing market research is based.
The growing prevalence of genetic diseases & increase in the adoption of next-generation sequencing are the growth drivers of the genetic testing market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials